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ABSTRACT 
Myelomeningocele (MMC) or spina bifida is a defect of the neural 
tube in which the spinal cord, its envelopes (meninges), and verte-
bral arches develop abnormally in the beginning of gestation, and 
owing to this failure of closure there appear a series of congenital 
defects and associated comorbidies, impairing in several aspects the 
functioning of the life of children with MMC. The congenital clubfoot 
has been found the most common orthopaedic anomaly in patients 
with MMC. The ankle-foot orthosis (AFO) is an orthopaedic device 
commonly used by these children to minimize the sequelae caused 
by this anomaly. Objective: Identify the functional benefits brought 
about by the use of the AFO to children with MMC, as reported by 
their guardians. Method: Descriptive, transversal study. Convenience 
sample consisting of 25 guardians of children with MMC who were 
using/had used an AFO. Results: Eighty percent of the guardians 
have reported at least one benefit brought about by the use of the 
AFO, among them: improvement in foot position (68%), foot growth 
(40%), improvement in foot balance (32%), and balance sitting posi-
tion (15%). Conclusion: The use of the AFO by children with MMC can 
provide several benefits reported by their guardians.
Keywords: Ankle-foot orthosis (AFO), myelomeningocele (MMC), be-
nefits, child, functioning, prevention.
RESUMO
A mielomeningocele (MMC) ou espinha bífida é um defeito do tubo 
neura no qual a medula espinal, seus envoltórios (meninges) e os 
arcos vertebrais desenvolvem-se anormalmente no início da gesta-
ção e, como consequências, temos uma série de defeitos congêni-
tos e comorbidades associadas prejudicando a funcionalidade em 
diversos aspectos da vida das crianças com MMC. O pé torto con-
gênito foi apontado como a anomalia ortopédica mais comum nos 
pacientes com MMC e a órtese tornozelo-pé (OTP) é um aparelho 
ortopédico que pode ser usado nessas crianças para amenizar as se-
quelas geradas por essa anomalia. Objetivo: Identificar os benefícios 
funcionais trazidos pelo uso da OTP em crianças com MMC relata-
dos pelos seus responsáveis. Método: Estudo descritivo, transversal. 
Amostra de conveniência composta por responsáveis de 25 crianças 
com MMC que usavam/usaram a OTP que responderam a uma en-
trevista estruturada que contemplava as variáveis estudadas. Resul-
tados: Oitenta por cento dos responsáveis relataram pelo menos um 
benefício causado pelo uso da OTP, dentre eles: melhorou a postura 
do pé (68%), o pé cresceu (40%), melhorou o equilíbrio em pé (32%), 
melhorou o equilíbrio sentado (15%). Conclusão: O uso da OTP em 
crianças com MMC pode proporcionar benefícios identificados pelos 
responsáveis. 
Palavras-chave: Órtese tornozelo-pé (OTP), mielomeningocele 
(MMC), benefícios, criança, funcionalidade, prevenção.
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INTRODUCTION
Myelomeningocele (MMC) or spina bifida cistica is 
one of the most complex congenital malformations 
compatible with life. Children born with this malfor-
mation may have lesions in the spinal cord as well as 
in the brain.1 Its global incidence varies from 0.1 to 
10 cases in each 1.000 live newborns. The highest 
incidence is associated with regions of low socioe-
conomic development, as shown in the congenital 
defect chart published by the World Health Organi-
zation in 2003.2 According to these data, the lowest 
incidences of spina bifida cistica in 1.000 live new-
borns occur in France/Paris (0.077) and England/
Wales (0.095), and the highest incidences occur in 
Mexico (1.525) and Venezuela (1.196).2 Brazil was 
mentioned in this study as occupying the fourth hi-
ghest place in the incidence of spina bifida cistica 
among the forty-one countries researched, with a 
1.139 rate in each 1.000 live newborns.2
Considering that the survival and quality of life 
of such patients are subject to neurological, urologi-
cal and orthopaedic complications, as well as general 
ones, it is important to stimulate prevention as well 
as diagnosis and early treatment of this incapacitating 
disease, aiming at reducing its impact on society.3 
The use of conservative methods of treatment du-
ring the first year of life can frequently prevent defor-
mities caused by wrong posture or by muscle action 
non-opposed by its antagonists. These deformities 
develop with the child’s growth and locomotion.4
Congenital clubfoot has been found the most 
common orthopaedic anomaly in patients with MMC 
in a reference hospital in Rio de Janeiro.5 The intro-
duction of the orthosis during the first year, for wei-
ght load, and the attempts on the part of the child to 
stand have been considered criteria for a gait and or-
thostatic posture training programme to be started.6
Orthoses can be described as a system of forces 
that can act over a given part of the human body, ai-
ming at various ends.7 The most evident indications 
for ankle orthosis are: secondary pain and instability, 
rigidity and deformities. For these problems, to en-
sure outside support, the essential type of orthosis is 
the traditional AFO (ankle-foot orthosis).7 AFOs are 
made of high temperature thermoplastics, and poly-
propylene is the most frequently used material in the 
making of such orthosis.7
The AFO should be used by the infant who alre-
ady presents contractures, with the aim of lengthe-
ning its soft tissues. It can be used on the anterior 
aspect when the goal is the correction of the calca-
neus valgus, or on the posterior one, when it is to 
maintain the foot in the plantigrade position, to im-
prove posture. If the AFO is used during sleep as well 
as part of the day, and if it is associated with passive 
movement, the acquired deformities of the foot tend 
to be less severe.4
The actual care for these children requires not 
only the adaptation of the family to the new routine, 
but also the learning of specific caring, such as vesical 
catheterism, administration of continuous use me-
dication, prevention of skin lesions, use of orthosis, 
among others.3
The objective of this study is to identify the be-
nefits of the use of an AFO accrued to children with 
MMC, recognised by their parents’ reports.
MATERIALS AND METHODS
This study has obtained the approval of the Ethics 
Committees of the participating Institutions 
(0063.1.008.231-10), and complies with the rules 
of Resolution 196/96 of the National Health Coun-
cil, and all the parents of the infants studied have 
signed an informed and free consent term (IFCT).
This is a descriptive and transversal study. The 
data were obtained by means of structured interviews 
with the parents of the children with MMC during 
a 13-month period, by the filling out of a question-
naire devised by the researcher. The data collected 
have been stored in a data bank (Excel) and a des-
criptive analysis was made with frequency distribu-
tion and central and dispersion trend measurements. 
The sample has been constituted according to the 
following inclusion criteria: children from 6 months 
to 3 years of age with MMC, who were using/had 
used an AFO, whose guardians had agreed to parti-
cipate in the research and to sign the IFCT. There 
have been no exclusion criteria.
The variables studied have been: the child’s gen-
der, level of the myelodisplasia, the child’s age, the 
child’s age at the moment of prescription of the 
AFO, the professional who has prescribed the AFO, 
the reason for its prescription, the recognition of 
any benefits, and the kind of the benefit(s) brought 
about by the use of the AFO.
The data were collected at Fernandes Figueira 
Institute (IFF – Fiocruz) because it is a highly-re-
Ankle-foot orthosis in myelomeningocele
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garded maternity hospital that cares for women with 
risk pregnancy and/or with foot uses presenting 
congenital anomalies. The data were also collected at 
Association of the Friends of Handicapped Children 
(AFHC) because it is a highly-regarded Rehabilita-
tion Centre in an under-privileged neighbourhood 
of Rio de Janeiro that cares for children with MMC 
who live there.
RESULTS
The parents of twenty-five children with MMC were 
found eligible for the study. Twenty-five parents of 
children from six and thirty-three months of age 
were interviewed (mean: 20.4; DP ± 7.7). The most 
frequent myelodysplasia was at the higher lumbar le-
vel (7/28%), followed by lower lumbar and sacral 
(6/24% each), thoracic (3/12%). In three children it 
was not possible to ascertain the level or the lesion. 
Distribution by gender: 14 female and 11 male. The 
most frequent moment of the AFO prescription was 
during the second semester of life (14/56%), follo-
wed by the first semester (10/40%) and the third se-
mester (1/4%).
Table 1 provides the distribution of the categori-
cal variables analysed. 
DISCUSSION
According to the literature, MMC can affect both 
genders in a similar way.8 Our sample revealed a slight 
predominance of the female gender, in agreement 
with some studies,9,10 but at variance with others.11,12 
As to the location of the lesion, some studies5,6,8,13-15 
have shown that the majority were found in lower 
lumbar and sacral levels. Our study has evidenced a 
higher incidence of the higher lumbar level (28%) 
and the majority was only affected at the lumbar le-
vel (52%). The differences above reported may have 
occurred owing only to the type of sample and the 
number of participants involved. According to the 
studies analysing the use of the AFO, the criteria 
for its prescription was contingent to the deambula-
tion prognosis, that is, patients with lesion at lower 
lumbar or sacral levels would be prescribed an AFO, 
since they would show a better prognosis for deam-
bulation.8,16,17
One review of literature showed that, besides the 
levels of the lesions, orthopaedic alterations were 
found in 40% of the articles analysed.18 The authors 
suggest that orthopaedic changes have as much im-
portance as the levels of the lesions in the deambula-
tory prognosis in MMC.18 In the present study, the 
referral to the use of an AFO seemed not to occur 
exclusively due to the deambulation prognosis, since 
40% of the children with MMC presented their le-
sion in higher lumbar/thoracic levels and yet/also 
used AFOs.
In children with MMC, the neurological level of 
the lesion can determine functional deficits characte-
rised by the wrong skeletal alignment which, if dis-
regarded, may turn deambulation problematic and 
later cause pain the joints. For this reason, functional 
deficits require orthotic treatment, to improve alig-
nment and protect lower members from pathologi-
cal forces that may limit mobility.19 Independently 
of the level of the lesion the AFO may be prescribed 
to patients with MMC for different reasons. In the 
group presenting thoracic or higher lumbar lesions, 
the AFO may be prescribed to prevent or correct 
deformities; in the group with lower lumbar or sa-
cral lesions, the AFO may be prescribed to improve 
orthostatic posture and gait, and need a good foot 
alignment.20 Children with a higher level lesion (tho-
racic) have worse prognosis for gait, but they need 
correct foot alignment for the use of a wheelchair. 
Abelheira LA et al.
Table 1. Distribution of the reasons of the AFO prescription, which professional 
prescribed it and the perception of benefits
Variable Category n %
Professional who prescribed the AFO Physician 15 60
Physiotherapist 10 40
Reason for prescription Prevent deformities 10 40
Correct deformities 10 40
Stand/walk 1 4
Don’t know 4 16
Perception of a benefit* Yes 20 90.9
No 2 9.1
Improvement in foot posture Yes 17 85
No 3 15
Improvement in balance for sitting Yes 3  15
No 17 85
Improvement in standing balance Yes 8 40
No 12 60
Growth of feet Yes 10 50
No 10 50
* Three did not know how to answer.
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Children with MMC who present any postural foot 
alteration need an AFO or corrective surgery follo-
wed by the use of orthosis.21 
The capacity a child with MMC should have of 
learning the world and of developing its individua-
lity is frequently impaired by its difficulty in actively 
assuming orthostatic postures (standing or sitting) 
and in locomotion. It is enough to watch how a 
twelve-month-old healthy baby explores its environ-
ment to realize how poor in experiments must be 
the world of the handicapped child; measures can be 
taken to avoid this dearth of experience.4 Individuals 
with MMC present a delay in their sensory-motor 
development, and one of the reasons for this is the 
alteration in the strength of lower members.22 For 
this reason they are referred to a follow-up in the 
areas of rehabilitation, including physiotherapy, with 
the aim of the improving muscular strength and the 
preventing contractions.22 Further objectives of the 
prescription of orthoses for the feet are: support 
load, reduce pressures, alleviate pain and improve 
mobility.23 The objectives of the prescription of the 
AFO in this study have been: prevent deformity of 
feet (40%), correct deformity of feet (40%) and assu-
me orthostatic stance/deambulate (4%); 16% of the 
parents had no knowledge of the reason for the AFO 
prescription. Our results point to objectives similar 
to those described in the literature, with the proviso 
that both prevention and correction of deformities 
have prevailed.
The introduction of the orthosis during the first 
year, for weight load, and the child’s attempts to 
stand have been considered enough reason to begin 
a training programme for gait and orthostatic pos-
ture.5 There has been concern, in our study, for the 
early use of the AFO, before the first year of life was 
complete, since the majority of the prescriptions were 
made during the first or second semesters of life. 
We have not found studies that had exclusive-
ly researched the benefits of the use of an AFO by 
patients with MMC. There are studies about deam-
bulation orthoses in which the AFO is coupled to a 
long tutor aiming at aligning the feet during gait.24-27
A child with MMC may show a delay in the de-
velopment of head and thorax control. It will take 
longer to balance itself in the sitting position whe-
never its head control is precarious, and it is slow in 
learning the postural adjustments specific to a task 
and its respective context, since the palsy of the lower 
members reduces the efficacy of the postural adjust-
ments in the sitting position, which demand bracing 
of feet or thighs.4
 It is known that for the deambulation of a child 
with MMC to occur, previous orthostatism training 
is necessary, and so that this training may occur with 
no lesions, the adequate alignment of the feet bea-
ring the weight of the child, that is, plantigrade feet, 
is of paramount importance.24,28,29 The benefits re-
ported in the present study confirm the data related 
in the literature, that AFOs may provide greater pos-
tural stability, thus affording their users the benefits 
of improved balance and posture.30
As far as we have been able to ascertain, this is the 
first study to consider the satisfaction of the parents 
of children with MMC with the use of the AFO.
The majority of parents (80%) reported having 
noticed at least one benefit resulting from the use 
of the AFO, such as: improvement in foot position 
(68%), growth of foot (40%), improvement of ba-
lance in orthostatic posture (32%), improvement of 
balance in sitting (32%).
In some researches, the importance of the family’s 
satisfaction regarding their relatives’ quality of life is 
emphasised.31-33 The needs of the children/families 
encompass physical, psychosocial and financial issues. 
One of the reasons for dissatisfaction is the inconve-
nience in obtaining service in the area of health.31
A disabling condition, such as MMC, may cause 
impairment to self care and mobility, and cause so-
cial isolation and low self esteem. This impairment 
directly affects the quality of life of children with 
MMC and of their families.30 A study affirms that the 
concept of quality of life represents a step forward 
in the perspective of enlargement the concepts good 
health/ill health, and that the presence of the stig-
ma linked to this condition causes dissatisfaction in 
young people, and interferes in their place in society 
as well as in their expression of happiness, social re-
cognition and self esteem, that is, in their quality of 
life.33
As a possible limitation of the present study, it is 
important to mention the high quality of the profes-
sionals who work in the two highly-regarded health 
care centres where the collection of data was conduc-
ted. The expertise of these professionals may have 
been the reason for their early prescriptions of the 
Ankle-foot orthosis in myelomeningocele
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AFO, which may have biased the positive/good re-
sults of this research.
CONCLUSION
The use of the AFO by children with MMC may af-
ford benefits recognised by their parents, and such 
a finding should be taken in consideration by the 
health professionals, for the prescription and the op-
timisation of the use of AFOs. The positive reports 
encourage the families of the children with MMC to 
try and improve the quality of their lives.
This study could assume the role of cathalystic of 
new researches that may allow the further examina-
tion of the issues here raised, such as the early use of 
AFOs by children with MMC and its benefits in the 
quality of life of these children. As a suggestion for 
future studies is the early intervention field, since the 
health professionals feel the need for more evidence 
in this area.
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